Leo I Gordon

Feinberg School of Medicine, Feinberg Clinical, Medicine, Hematology Oncology Division

Leo I Gordon

Research Interest Keywords

Apoptosis, Bone Marrow Transplantation, Cancer Biology, Cancer: Blood (leukemia, lymphomas), Hodgkin's Disease, Leukemia, Lymphomas, Monoclonal Antibodies, Non-Hodgkin's Lymphoma, Stem Cells, Transplantation

Office phone

312/695-4546

Email

Scopus Publication Detail

The publication detail shows the title, authors (with indicators showing other profiled authors), information on the publishing organization, abstract and a link to the article in Scopus. This abstract is what is used to create the fingerprint of the publication.



Use of total leukocyte and platelet counts to guide stem cell apheresis in healthy allogeneic donors treated with G-CSF

M. Tomblyn; L.I. Gordon; S. Singhal; M.S. Tallman; S. Williams; J.N. Winter; A. Evens; J. Mehta (Profiled Authors: Leo I Gordon; Jayesh Mehta; Seema Singhal; Stephanie Williams; Jane Norma Winter)

Bone Marrow Transplantation. 2005;36(8):663-666.

Abstract

Healthy stem cell donors start leukapheresis 4 -5 days after starting G-CSF based on the peripheral blood CD34+ cell count (PBCD34). Data from 137 harvests (68 donors) were analyzed to determine correlation between pre-apheresis leukocytes (11.0-94.8 × 10 9/l; median 38.8) and platelets (49-374 × 10 9/l; median 180), and PBCD34 (3 -276/μl; median 40). PBCD34 correlated positively with leukocytes (r=0.48; P<0.0001) and platelets (r=0.40; P<0.0001). When pre-apheresis leukocytes were ≥25 and platelets were ≥100, PBCD34 and CD34+ collection were 5-276/μl (median 57) and 0.5-27.6 × 10 6/kg (median 4.7), respectively; significantly higher than PBCD34 of 3-74/μl (median 17) and CD34+ collection of 0.2-8.9 × 10 6/kg (median 2.2) when leukocytes were <25 and/or platelets were <100. With leukocytes ≥25 and platelets ≥100, PBCD34 was low (<20/μl) 8% of the time, compared to 57% of the time with leukocytes <25 and/or platelets <100 (P<0.0001). Our data suggest that it is not always necessary to measure PBCD34 to guide leukapheresis in healthy donors because pre-apheresis leukocytes and platelets ≥25 and ≥100, respectively, are associated with excellent mobilization. When blood counts do not meet these criteria, PBCD34 should be determined prior to initiation of apheresis. © 2005 Nature Publishing Group. All rights reserved.


PMID: 16062175    

Scientific Context

This section shows information related to the publication - computed using the fingerprint of the publication - including related publications, related experts with fingerprints representing significant amounts of overlap between their fingerprint and this publication. The red dots indicate whether those experts or terms appear within the publication, thereby showing potential and actual connections.

Related Publications

Related Experts

Author of this Document